Unraveling the Mechanism: Scientists Pinpoint the Crucial Role of the Fc Fragment in Lecanemab’s Alzheimer’s Plaque Clearance
A groundbreaking study by scientists at VIB and KU Leuven has definitively illuminated the precise mechanism by which lecanemab, the monoclonal antibody treatment marketed as Leqembi, combats Alzheimer’s disease. This…
Heidelberg University Team Uncovers Novel Molecular Pathway Driving Alzheimer’s Progression, Offering New Therapeutic Avenues
A groundbreaking study spearheaded by Professor Dr. Hilmar Bading, a distinguished neurobiologist at Heidelberg University, has illuminated a critical molecular mechanism at the heart of Alzheimer’s disease progression. Collaborating with…
New Study Uncovers Tanycytes’ Crucial Role in Alzheimer’s Disease Pathology
The accumulation of tau protein in the brain is a defining hallmark of Alzheimer’s disease, a devastating neurodegenerative condition affecting millions worldwide. Now, a groundbreaking study published on March 5…
A Groundbreaking Cellular Immunotherapy Shows Promise for Alzheimer’s with a Single Injection
The landscape of Alzheimer’s disease treatment is on the cusp of a significant transformation, moving beyond therapies that merely slow progression to potentially reversing some of the underlying pathology. While…
A Novel Blood Test Revolutionizing Alzheimer’s Detection: Structural Protein Changes Offer Unprecedented Diagnostic Accuracy
Alzheimer’s disease, a relentless neurodegenerative condition, casts a long shadow over millions of lives, with an estimated 7.2 million Americans aged 65 and older affected, according to the Alzheimer’s Association.…
Unlocking Alzheimer’s Plaque Clearance: VIB and KU Leuven Scientists Reveal Crucial Role of Antibody’s Fc Fragment in Microglial Activation
A groundbreaking study by scientists at the VIB and KU Leuven has precisely delineated the mechanism by which lecanemab, marketed as Leqembi, a monoclonal antibody treatment for Alzheimer’s disease, effectively…












